Concepedia

Thomas Ullrich

TU

Statistics

Publications

29

Citations

1.2K

H-Index

19

Active since

1997

Affiliations

National Institutes of Health(Current)

National Institute of Diabetes and Digestive and Kidney Diseases

Novartis (Switzerland)

Novartis (Austria)

University of Michigan

Thomas Ullrich is an author at National Institutes of Health specializing in pharmacology, medicine, and neuropharmacology.

ORCID

Publications per year

1997–2022

29

Publications

29

3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement

William E. Fantegrossi, Thomas Ullrich, Kenner C. Rice et al. · Psychopharmacology · 2002 · 142 citations · Full text

, , +14

Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice

William E. Fantegrossi, Tomek Godlewski, Rachel Lynn Karabenick et al. · Psychopharmacology · 2003 · 119 citations · Full text

, , +16

Regulation and Traffic of Ceramide 1-Phosphate Produced by Ceramide Kinase

Alistair Boath, Christine Gräf, Emilie Lidome et al. · Journal of Biological Chemistry · 2007 · 112 citations · Full text

, , +11

Synthesis of Borondipyrromethene (BODIPY)-Labeled Sphingosine Derivatives by Cross-metathesis Reaction

Carsten Peters, Andreas Billich, Michael Ghobrial et al. · The Journal of Organic Chemistry · 2007 · 94 citations

, , +9

Developmentally inspired programming of adult human mesenchymal stromal cells toward stable chondrogenesis

Paola Occhetta, Sébastien Pigeot, Marco Rasponi et al. · Proceedings of the National Academy of Sciences · 2018 · 81 citations · Full text

, , +17

1–5 of 29